RightMove Appoints Marcus Osborne as CEO; Frist Cressey Ventures and Greycroft Join Series A Financing
RightMove Powered by HSS, a nationwide provider of virtual musculoskeletal physical therapy co-founded by Hospital for Special Surgery (HSS) and Flare Capital Partners, has appointed former Walmart Health executive Marcus Osborne to be its Chief Executive Officer.
RightMove, which was announced in October and will launch mid-2023, also announced that leading venture capital firms Frist Cressey Ventures and Greycroft have joined HSS and Flare Capital Partners in its Series A financing.
Specialized in musculoskeletal health for 160 years, HSS is the world’s leading academic medical center dedicated to the field, ranked #1 in orthopedics worldwide by Newsweek and nationwide by U.S. News & World Report. Half of all U.S. adults experience musculoskeletal health-related issues leading to an annual national health expenditure of over $380 billion USD, and rising. Access to high-quality physical therapy has been shown to reduce unnecessary surgeries, injections, emergency room visits, and imaging - resulting in better outcomes at a lower cost for patients, employers and payors.
“RightMove connects the world’s largest concentration of knowledge and expertise in musculoskeletal health that is HSS to the enormous need for better quality diagnosis and treatment at population scale,” said HSS CEO Louis A. Shapiro. “Marcus Osborne, Frist Cressey Ventures and Greycroft each bring to this their own singular strengths and together with Flare Capital Partners, we can positively transform quality and performance for millions nationwide.”
For 15 years, Mr. Osborne played a key role in Walmart’s push into healthcare. Announcing his move from Walmart last year, he said: “I’m not done trying to do what I can to make things a little better—I’m just going to do it while on a different path." Mr. Osborne’s official start date as CEO of RightMove Powered by HSS is February 13.
Since the October announcement of the independent for-profit company’s formation and Series A financing, Amy Fahrenkopf, MD, senior vice president of HSS and president of HSS Health, has served as interim CEO of RightMove. “We are delighted and encouraged to have secured both the iconic leadership of Marcus Osborne and partnerships with visionary investors Frist Cressey Ventures and Greycroft, particularly in the context of a challenging capital market,” said Dr. Fahrenkopf.
Prior to earning his MBA at Harvard in 2007, Mr. Osborne completed an internship at The White House and served as Chief Financial Officer of the Clinton Foundation’s HIV/AIDS Initiative. Since leaving as Senior Vice President of Walmart Health, Mr. Osborne has joined the Board of Directors of five early stage wellness and healthcare companies and serves as Executive Chairman of one of those.
“The number of Americans dealing with chronic musculoskeletal issues is staggering,” said Marcus Osborne. “The opportunity to work with a best-in-class institution in HSS and phenomenal investors in Flare Capital Partners, Frist Cressey Ventures and Greycroft to deliver a next-generation solution to market to help address this massive problem is one that I’m enormously excited by.”
Co-founded by former U.S. Senate Majority Leader Bill Frist, MD, and private equity pioneer Bryan Cressey, Frist Cressey Ventures is a venture capital firm with a mission of transforming healthcare to improve lives. “We don’t believe that the status quo of musculoskeletal care available to the average American is good enough,” said Navid Farzad, Partner at Frist Cressey Ventures. “We’re grateful to be a part of the RightMove team and bring the world-class clinical excellence in musculoskeletal care at HSS to more people.”
Greycroft’s portfolio spans investments in a broad range of internet sectors, with companies headquartered in 19 countries. It concentrates on long-term, values-based opportunities with businesses committed to teamwork. “At Greycroft, we look to invest in areas like health tech that are rapidly evolving. In particular, we see an immediate opportunity to transform how MSK care is delivered and experienced. HSS is the premiere center for musculoskeletal health and we are thrilled to leverage their clinical expertise and data-driven approach to bring an innovative solution like RightMove to market,” said Greycroft Partner Ellie Wheeler.
About Flare Capital Partners
Flare Capital Partners strives to help build significant healthcare technology, digital health, and healthcare services companies to improve health outcomes and broaden access while lowering costs of care. We partner with inspirational entrepreneurs who seek to transform the business of healthcare by developing innovative and impactful products and services. Flare Capital Partners is a team of proven healthcare technology investors and senior operating executives known for thought leadership and unparalleled strategic industry resources. Our firm has raised some of the industry’s largest dedicated venture capital funds focused on early-stage opportunities in healthcare technology innovation, and our investors include leading healthcare companies, major institutional investors, important family offices, foundations, and sovereign wealth funds. We support portfolio companies over the entire company-building journey. Select portfolio companies include Aetion, Aspen RxHealth, Bright Heath, Cayaba Care, Circulation, Cohere Health, Eden Health, HealthVerity, Inbound Health, Iora Health, Oshi Health, Somatus, and VisitPay. The firm has developed the very successful Flare Scholar program with over 300 participants who have already gone on to sponsor 15 pre-seed companies. Additionally, the firm actively leverages its extended industry network, Executive Partners, and Industry Advisory Board for the benefit of the entrepreneurs and founders with whom it is privileged to partner. Learn more at www.flarecapital.com and follow the firm on Twitter @flarecapital.
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 14th consecutive year), No. 2 in rheumatology by U.S. News & World Report (2023-2024), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report “Best Children’s Hospitals” list (2023-2024). In a survey of medical professionals in more than 20 countries by Newsweek, HSS is ranked world #1 in orthopedics for a third consecutive year (2023). Founded in 1863, the Hospital has the lowest readmission rates in the nation for orthopedics, and among the lowest infection and complication rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center five consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. In addition, more than 200 HSS clinical investigators are working to improve patient outcomes through better ways to prevent, diagnosis, and treat orthopedic, rheumatic and musculoskeletal diseases. The HSS Innovation Institute works to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is a trusted leader in advancing musculoskeletal knowledge and research for physicians, nurses, allied health professionals, academic trainees, and consumers in more than 165 countries. The institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. www.hss.edu.